Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model

Sifeng Qu(BC Cancer Agency), Yuzhuo Wang(BC Cancer Agency)
Molecular Oncology
December 15, 2013
Cited by 34


Related Papers